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Abstract
Introduction: There are scarce data on immunochemical properties of pemphi-
gus antibodies detected in clinical remission in pemphigus vulgaris (PV) patients.
The aim of the study was to compare biological activity of anti-Dsg3 autoanti-
bodies purified from the sera of PV patients in active stage and in clinical remis-
sion.
Material and methods:  The effect of purified antibodies on expression of pro-
caspase-3, Bax, Bcl-2, uPAR, IL-1β, IL-6, and TNF-α mRNAs in the HaCaT ker-
atinocytes was evaluated by Western blot and RT-PCR method.
Results: Incubation of HaCaT cells with anti-Dsg-3 autoantibodies caused their
binding to cell membranes surfaces. Anti-Dsg3 autoantibodies isolated from the
patients in active stage and clinical remission showed proapoptotic effect, caused
enhanced expression of analyzed proinflammatory cytokines’ mRNAs and uPAR
mRNA.
Conclusions: Our data revealed similar pathogenic activity of anti Dsg-3 autoan-
tibodies isolated from active and clinical remission PV patients. 
Key words: pemphigus vulgaris, anti-Dsg-3 antibodies, acantholysis, keratinocyte
culture, apoptosis.
Introduction
Pemphigus is an autoimmune blistering disease, affecting skin and
mucous membranes. It is a life-threatening disease which demands long-
lasting immunosuppressive treatment. Pemphigus is divided into two dis-
tinct subtypes: pemphigus vulgaris (PV) and pemphigus foliaceus (PF). The
antigens in pemphigus are desmogleins (Dsg), transmembrane desmoso-
mal glycoproteins belonging to the cadherins supergene family of calcium-
dependent adhesion molecules. The Dsg 1 (160 kDa) is the autoantigen rec-
ognized by PF antibodies, whereas Dsg3 (130 kDa) is recognized by PV
antibodies. However, in about 50-70% of PV patients’ sera anti-Dsg1 autoan-
tibodies are present as well [1]. Anti-Dsg autoantibodies interfere with the
adhesive function of desmogleins and cause loss of cell-cell adhesion.
Recent studies suggest that IgG pemphigus autoantibodies may uniquely
react with, apart from desmogleins, approximately 20 proteins (molecular
masses range from 12 kDa to 219 kDa) which also may play an important
role in acantholysis development [2, 3]. Despite extensive research, the
Corresponding author:
Joanna Narbutt MD, PhD
Department of Dermatology
and Venerology
Medical University of Lodz
5 Krzemieniecka
94-017 Lodz, Poland
Phone: +48 42 686 79 81
Fax: +48 42 688 45 65
E-mail:
joanna.narbutt@umed.lodz.pl
Clinical research
1Department of Dermatology, Medical University of Lodz, Poland
2Centre of Medical Biology, Polish Academy of Sciences, Lodz, Poland 
3Department of Dermatology, Medical University of Warsaw, Poland
Submitted: 7 July 2010
Accepted: 18 August 2010
Arch Med Sci 2012; 8, 2: 347-356
DOI: 10.5114/aoms.2012.28564
Copyright © 2012 Termedia & Banach348 Arch Med Sci 2, April / 2012
J. Narbutt, J. Boncela, K. Smolarczyk, C. Kowalewski, K. Wozniak, J.D. Torzecka, A. Sysa-Jedrzejowska, C.S. Cierniewski, A. Lesiak
exact aetiopathogenesis of pemphigus is still unclear
and no objective criteria of complete cure of the dis-
ease have been established so far. The direct
immunofluorescence test (DIF) detecting bound in
vivo IgG deposits in the intercellular spaces of the
epidermis and the indirect immunofluorescence test
(IIF) showing circulating IgG antibodies are routine
examinations in diagnosing pemphigus, and their
negative findings may indicate stopping treatment. 
In some cases, however, despite long lasting treat-
ment and lack of clinical symptoms, both immuno-
logical examinations are still positive. It seems con-
troversial, especially because most dermatologists
assume a strong correlation between the titre of
pemphigus antibodies and the disease activity. There
are scarce data on immunochemical properties of
antibodies detected in clinical remission and their
potential ability to initiate acantholysis. In this
process various pathways including proinflammato-
ry cytokine mRNA expression and apoptosis are
involved. Apoptosis is a physiological process essen-
tial for the maintenance of homeostasis by elimina-
tion of damaged or mutated cells. Multiple pathways
and a variety of environmental, extracellular and
internal signals are responsible for the activation and
regulation of this process [4]. Classical apoptosis
requires activation of caspases. Caspase-dependent
apoptosis is activated through either receptor (exter-
nal) or mitochondrial (internal) pathways. One of the
main regulators of apoptosis is the family of Bcl-2
proteins, consisting of both apoptosis inhibitors, such
as Bcl-2 and Mcl-1, and pro-apoptotic proteins, such
as Bax, Bak and Bad. The ratio of Bax : Bcl-2 deter-
mines the death or life of the cells [5]. Both initiator
caspase pathways activate effector caspases sub-
sequently, mainly caspase-3, and caspases-6 and
caspases-7 to a lesser extent [6]. In addition, one of
the signals leading to apoptosis is DNA damage,
inducing cell death by the pathway orchestrated by
members of the p53 (p53, p73) and Bcl-2 families [7].
Although there are many data on the role of apop-
tosis in multiple skin diseases, its role in pemphigus
development is still not clear. 
In keratinocyte cultures stimulated with PV-IgG,
in the presence of IFN-γ, enhanced expression of
FasR, FasL, caspases and DNA degradation were
observed after 10-30 h, while acantholysis was not-
ed only after 2-3 days. Immunohistochemical analy-
sis showed increased expression and altered dis-
tribution of proteins belonging to DISC and FADD
families, as well as enhanced expression of cas-
pase-8 and caspase-3. These phenomena led to
intra-epidermal blister formation. These results sug-
gest that apoptosis is followed by acantholysis [8]. 
In another study, Frusic-Zlotkin et al. [9] revealed
that keratinocyte and organ cultures upon incuba-
tion with PV-IgG had increased activity of caspase-3
and caspase-8 and these authors used caspase
activity to monitor biological properties of pem-
phigus antibodies in regard to their binding to
epithelia. Wang et al. [10] revealed that PV-IgG anti-
bodies induced Fas-dependent apoptotic events and
their activity depends on culture age. They showed
that aged human keratinocyte cultures are more
sensitive to PV-IgG mediated apoptotic phenome-
na than younger ones, which may partially provide
some explanation for late onset of PV. It was also
suggested that dysregulation of apoptotic path-
ways and no proper clearance of apoptotic materi-
al in PV patients my act as antigens and in conse-
quence lead to autoantibody synthesis [11]. Most
studies on apoptosis in pemphigus have been per-
formed with the use of IgG antibodies isolated from
active patients. There are no published papers con-
cerning apoptotic activities of purified anti-Dsg3
antibodies isolated either from active PV patients
or from patients in clinical remission. 
Although the pathogenic role of pemphigus
autoantibodies is widely proven, more and more
studies indicate the possibility of their occurrence
in 30-70% of healthy relatives of pemphigus
patients [12, 13]. In these cases we can detect by
IIF antibodies of a pattern typical for pemphigus
(fishnet-like) in the intercellular spaces of epitheli-
um (monkey and/or guinea-pig oesophagus). This
pattern is identical to a true ‘pemphigus’ one, and
in most cases distinguishing between them is
impossible. In the individuals in whom circulating
antibodies are detected, DIF is usually negative, indi-
cating the lack of reactions of these antibodies with
target pemphigus antigens in the epidermis. In our
studies performed in healthy relatives of pemphi-
gus patients we detected circulating autoantibod-
ies in 40% of cases by IIF [14]. According to our
knowledge, there are no studies on the immuno-
chemical properties and potential pathogenic role
of IgG antibodies taken from this sero-positive
group of healthy relatives of PV patients. 
The aim of our study was to evaluate biological
activity of anti-Dsg3 antibodies, immunoche  -
mically purified from patients with the active stage
of PV and patients on maintenance treatment 
(clinical remission). Additionally we checked
whether IgG antibodies isolated from healthy rela-
tives of PV patients in whom IIF showed circulat-
ing pemphigus antibodies in low titres have similar
properties. The effect of examined antibodies on
expression of procaspase-3, Bax, Bcl-2, urokinase
plasminogen activator receptor (uPAR), IL-1β, IL-6,
and TNF-α mRNAs in the HaCaT keratinocytes was
evaluated. 
Material and methods
Patients
To isolate autoantibodies we used sera obtained
from: (1) patients in an active stage of disease Arch Med Sci 2, April / 2012 349
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(n = 18; 6 M and 12 F), (2) in clinical remission 
(n = 14; 7 M and 7 F), (3) healthy relatives (n = 5;
1 M and 4 F) of patients with pemphigus and (4)
control donors (n = 7). Pemphigus was diagnosed
based on clinical picture, histological examination
(acantholysis and intra-epidermal blister formation),
DIF (bound in vivo IgG deposits in intercellular
spaces of spinous layer of epidermis) and IIF (cir-
culating pemphigus antibodies). Clinical remission
was considered when patients presented with no
mucocutaneous skin lesions at least for 6 months
and were on maintenance therapy (mean pred-
nisone dose 40 mg every second day and mean
cyclophosphamide dose 50 mg every second day).
The healthy relatives group consisted of the rela-
tives of PV patients who selectively showed circu-
lating pemphigus antibodies in IIF with no simulta-
neous presence of any skin or mucous lesions. The
control donors group consisted of sera obtained
from healthy unrelated subjects, age and sex
matched. The study protocol was approved by the
Ethics Committee of the Lodz Medical University.
All subjects gave written informed consent before
entering the study. 
All sera were examined by IIF using commercially
available substrates: guinea pig and monkey
oesophagus (Euroimmune, Lubeka, Germany) by
a standard procedure [15]. Mean titres of pemphi-
gus autoantibodies obtained from patients in the
active stage of the disease, in the remission phase
and those of healthy relatives were 1/1280, 1/320,
1/160, respectively. The same sera samples were
examined by ELISA (MESACUP DESMOGLEIN TEST
Dsg-1 and Dsg-3; MBL Co. Ltd, Nagoya, Japan)
according to the manufacturer’s instructions. ELISA
index was assessed as positive when it was high-
er than the cut-off for Dsg-1 and Dsg-3 equalled 14
and 7, respectively. Mean indices of anti-Dsg-3 anti-
bodies obtained from patients in the active stage
of the disease and in the remission phase were 144
IU/ml and 96 IU/ml, respectively. In sera of the
healthy relatives the ELISA test gave negative
results. All sera were heated at 56°C for 30 min to
inactivate complement, aliquoted and stored at 
–80°C. 
Methods
Expression of recombinant Dsg-3 in Escherichia
coli and purification
To express the recombinant protein fragment
corresponding to the entire extracellular domain of
Dsg-3 (1715 bp), two cDNA fragments (1281 bp and
434 bp) were PCR amplified using cDNA obtained
from HaCaT cells with the following primers:
5’ggcaaggatccgaatgggtgaaatttg 3’ and 5’ ggcaattt-
tagaattcaagtggtttgg 3’; 5’ccaaaccacttgaattc-
taaaattgcc 3’ and 5’ gcaggctcgagcctccctgagtg 3’. The
1281 bp PCR product was digested with BamHI and
EcoI restriction enzymes and cloned into pRSET
A plasmid (Invitrogen). The obtained plasmid was
then used for cloning the second 434 bp PCR prod-
uct using EcoRI and XhoI restriction sites. The full
insert was sequenced and proved to be in the cor-
rect frame. Thus, the rDsg-3 fragment was
expressed with high efficiency in E. coli BL 21(DE3)
strain as a His-tag fusion protein containing 12 addi-
tional residues (MRGSHHHHHHGS) at its N-termi-
ni. The recombinant Dsg-3 fragment was next iso-
lated from inclusion bodies dissolved in 6 M urea
by chromatography on a Chelating Sepharose Fast
Flow column (Amersham Biosciences), loaded with
Ni ions according to the manufacturer’s instructions.
Purification and refolding of recombinant Dsg-3 was
performed as described in [16, 17]. 
Isolation of patient autoantibodies
Autoantibodies were purified from sera of
patients by affinity chromatography using the
immobilized recombinant fragment of Dsg-3 cor-
responding to its entire extracellular fragment. For
this purpose, rDsg-3 was bound to Chelating
Sepharose Fast Flow resin (Amersham Biosciences)
loaded with Ni ions. Briefly, sera samples were incu-
bated with the resin at 4°C overnight with gentle
rocking and then antibodies bound to the rDsg-3–
His resin were eluted with the IgG elution buffer
(100 mM glycine, pH 3.0), immediately neutralized
with 0.5 M Tris-HCl, pH 8.0, dialysed against phos-
phate-buffered saline (PBS, pH 7.4) and concen-
trated with a Microsep 30 microconcentrator. As
anti-Dsg-3 antibodies were undetectable by ELISA
in sera of healthy relatives, despite the presence of
pemphigus antibodies found by IIF in this group of
subjects, their entire IgG fraction was isolated. IgGs
from healthy relatives were isolated using the stan-
dard technique with HiTrap Protein A HP columns
according to the manufacturer's instructions (Amer-
sham Biosciences). The IgG samples were fraction-
ated by precipitation with 40% ammonium sulfate,
dialysed against PBS, and concentrated using
a Microsep 30 microconcentrator (Pall Life Science,
Ann Arbor, MI, USA). The purity of isolated IgGs was
monitored by western immunoblotting and its bind-
ing specificity tested by ELISA. Purified autoimmune
IgGs were stored at the concentration of 10 mg
per ml in PBS at –80°C.
Cell culture
A spontaneously immortalized human ker-
atinocyte cell line, HaCaT [18], was cultured in
DMEM supplemented with 100 U/ml penicillin,
100 μg/ml streptomycin, and 10% FBS at 37°C in an
atmosphere of 5% CO2. For experiments, cells were
subcultured in 6-well plates and maintained to 90%350 Arch Med Sci 2, April / 2012
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confluency. Then, the culture medium was dis-
carded, and the cells were pre-incubated in DMEM
supplemented with 0.1% BSA for 24 h. For mRNA
analysis, the medium was replaced with fresh
serum-free medium containing autoimmune or con-
trol IgG (1 mg/ml). Cells were harvested after 24 h
and total mRNA isolated.
Assessment of mRNA levels
Total RNA was extracted from the keratinocytes
by the Micro-to-Midi Total RNA Purification system
(Invitrogen, Carlsbad, CA, USA). The first strand of
cDNA was synthesized according to the manufac-
turer’s instructions (Promega Corp., Madison, WI,
USA) using oligo dT primer. The reverse transcription
was carried out for 60 min at 30°C and stopped at 4°C.
The primer sequences for amplification of TNF-α, 
IL-6, IL-1 and u-PAR mRNAs were 5’gtagcccatgttg-
tagcaaacc 3’ and 5’gaggacctgggagtagatgagg 3’,
5’acctgaaccttccaaagatgg 3’ and 5’gactgcaggaactc-
cttaaagc 3’, 5’ctcgccagtgaaatgatgg 3’ and 5’gcatcttc-
ctcagcttgtcc 3’, and 5’ ggtgaagaagggcgtccaaagg 3’
and 5’ ttctgcggcagattttcaagctc 3’, respectively. 
RT-PCR assay conditions were as follows: 1 μl of
cDNA sample, 20× Tfl polymerase buffer, 2.5 mM
MgCl2, 1× PCR enhancer, dNTP mix, 25 pmol of each
primer and 1 U of Tfl DNA polymerase (Epicentre
Biotechnologies, Madison, WI, USA) in 25 μl reac-
tion volume. The samples were denatured at 95°C
for 5 min, then cooled on ice and the enzyme was
added. The reaction was performed in 25 to 30 ex  -
tension cycles consisting of a 30 s denaturation 
step at 94°C, a 30 s annealing step at 55°C, and 
a 30 s polymerase extension step at 72°C. Finally,
each reaction was terminated with a 10 min elon-
gation step at 72°C. To detect actin mRNA, the same
protocol was used with the oligodeoxyribonu-
cleotide primers 5’cagcagattcaagcagctatgg3’ and
5’gtctgtggtgctgatctcatcc3’. The final products, TNF-α,
IL-6, IL-1β and actin mRNAs, were separated by elec-
trophoresis in 1.5% agarose gels in TAE buffer using
the genetic size marker 100 bp DNA Ladder
(Promega). Bands were visualized by UV light, record-
ed photographically and analysed densitometrically
using MultiImageTMFC Cabinet and FlourChemTMIS-
8800 Software v.3.0 (Alpha Innotech Corp., San
Leonardo, CA, USA). Concentrations of mRNA in each
sample were normalized in relation to β-actin mRNA.
Usually 4-6 bands were analysed for each sample
and the mean value was calculated. The mean ± SD
was then calculated for each group.
Western blot analysis
HaCaT cells were incubated in serum-free medi-
um (KSFM, GIBCO-Invitrogen) in the presence or
absence of PV autoantibodies or normal human IgG
for 8 h. Cell lysates were prepared using RIPA buffer
(Pirece Co.) and protein concentrations were deter-
mined using the BCA method. One hundred μg of
protein from each of the cell lysates was loaded
into SDS/PAGE and then gels were transferred onto
nitrocellulose membranes (BioRad). Next, mem-
branes were incubated for 1 h at room temperature
with polyclonal rabbit antibodies to human procas-
pase-3 (Santa Cruz), or monoclonal antibodies to
human Bcl-2 (Santa Cruz), Bax (Santa Cruz) or actin
(Santa Cruz), respectively. Bound antibodies were
detected with corresponding second antibodies con-
jugated with horseradish peroxidase, namely mouse
anti-rabbit immunoglobulin (Promega) or goat anti-
mouse (Santa Cruz), respectively. All antibodies were
used at a dilution according to the manufacturer’s
instructions. Bands were visualized by autoradiog-
raphy with ECL Reagent (Pierce Co.)
Confocal microscopy
Cells were grown directly (5 × 104 cells/ml) on
tissue culture chamber slides (Nunc). After 24 h
incubation in the presence of PV autoantibodies
(1 mg/ml) or normal human IgG (1 mg/ml), HaCaT
cells were rinsed 3 times with cold PBS and dipped
in –20°C methanol for 20 min. Next, cells were
stained with Texas Red-X phalloidin according to
the manufacturer’s instructions (Molecular Probes)
to visualize actin filaments and analysed with a flu-
orescence microscope (Nikon). In some experi-
ments, cells grown (5 × 104 cells/ml) on tissue cul-
ture chamber slides (Nunc) for 18 h were used to
dye their nuclei with Hoechst 33342 (Molecular
Probes). Then they were rinsed 3 times with cold
PBS and fixed with 3% paraformaldehyde for 
20 min on ice and blocked with 10% normal goat
serum (Santa Cruz). Afterwards, cells were incu-
bated with PV autoantibodies (1 mg/ml) or normal
human IgG (1 mg/ml) for 1 h at room temperature
and treated for 1 h with goat anti-human IgG-TRIC
(Santa Cruz) used at the dilution of 1 : 100. Finally,
slides were rinsed with PBS, and chambers were
removed and mounted with glass slides in mount-
ing media with 3% DABCO (Sigma).
Statistical analysis
Statistical analysis was performed using Statis-
tica v.5.0 and GraphPad Prism v.4.03. As laboratory
data did not fit a Gaussian distribution according
to the Shapiro-Wilk test, all results were expressed
by the median (50th percentile) and interquartile
range (25th–75th percentile), and non-parametric
tests were used to test statistical significance of
differences in laboratory parameters. To avoid errors
inherent in repeated application of Mann-Whitney
U tests, the Kruskal-Wallis test was performed to
make simultaneous comparison of the assay data
from each of the three groups of subjects, and toArch Med Sci 2, April / 2012 351
determine if there was significant variation in the
medians of the groups analysed. If it achieved 95%
significance, Dunn’s multiple comparison post-test
was used to compare the assay results of one
group with another. 
Results
Isolation and characterization of anti-Dsg-3
autoantibodies 
The recombinant fragment of Dsg-3 correspon-
ding to its entire extracellular domain was
expressed in E. coli as a His-tag fusion protein, puri-
fied on nickel chelating columns in 6 M urea, and
refolded by sequential dialysis to remove the denat-
urant. The final product was soluble in aqueous
buffers and was homogeneous as assessed by SDS-
PAGE (Figure 1 A). This protein was then used to
isolate autoantibodies from blood sera of pemphi-
gus vulgaris patients in an active stage of disease
or in clinical remission. For this purpose, rDsg-3 was
bound to Chelating Sepharose Fast Flow resin
(Amersham Biosciences) loaded with Ni ions, after
overnight incubation with samples of patient sera,
antibodies bound to the rDsg-3–His resin were elut-
ed with 0.1 M glycine buffer, pH 3.0, and immedi-
ately neutralized. Anti-Dsg-3 autoantibodies sepa-
rated by SDS PAGE showed homogeneity (Figure 1 B).
When immobilized on microtitre plates, the 
recombinant rDsg-3 fragment reacted with both
types of autoantibodies, namely those isolated from
patients with the active state of PV or with disease
remission, respectively (Figure 1 C). Incubation of
HaCaT cells with anti-Dsg-3 autoantibodies resulted
in their binding to cell membrane surfaces (Figure 2
A-B). Autoantibodies were mostly found in regions
adjacent to the plasma membrane, but to some
extent there was also diffuse staining in the whole
cytoplasm. This staining was specific since IgGs
obtained from healthy or control donors were neg-
ative in control cells additionally stained with Hoechst
33258 to visualize their nuclei (Figure 2 C-D). 
Anti-Dsg-3 autoantibodies from pemphigus 
vulgaris patients in active or remission phase
differ in their anti-adhesive activity
In the next experiments we compared the effect
of autoantibodies on the actin filament network in
keratinocytes after staining of cells with TRITC-phal-
loidin (Figure 3 A). Incubation of HaCaT cells for 
24 h with anti-Dsg-3 autoantibodies isolated from
patients in the active stage of the disease resulted
in reorganization of the actin cytoskeleton typical
for apoptotic cells (Figure 3 A, picture a). The micro-
filament system of such cells was focally enriched
in regions located subjacent to the plasma mem-
brane and nucleus. In contrast, cells treated with
control IgG obtained from healthy relatives or con-
trol donors showed a well-developed system of the
actin filament network typical of adhering and
spread cells. They also formed intercellular con-
nections (Figure 3 A, pictures c and d). Interesting-
ly, HaCaT cells incubated with anti-Dsg-3 autoanti-
bodies isolated from patients in the remission
phase were more similar to control cells with the
actin filament network near normal and showing
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Figure 1. Characteristics of recombinant Dsg-3 and
anti-Dsg-3 autoantibodies. Recombinant proteins
expressed in E. coli and purified by affinity chro-
matography on Chelating Sepharose Fast Flow resin
were separated by SDS-PAGE and immunoblotted
with serum obtained from PV patients used at the
dilution 1 : 1000 (panel A, lane a) and normal human
serum used as a negative control (panel A, lane b).
Recombinant Dsg-3 was used to isolate autoanti-
bodies from PV patients’ sera. Purified IgGs were sep-
arated by SDS-PAGE and immunoblotted with rab-
bit anti-human IgG conjugated with horseradish
peroxidase and visualized by ECL. The affinity puri-
fied autoantibodies from PV patients in active state
(panel B, lane a) or in remission stage (panel B, lane
b) appeared to be homogeneous. Panel C shows
binding of anti-Dsg-3 antibodies purified from serum
of patients of active stage (°-°) or in remission (•-•)
detected by solid phase binding assay. For this pur-
pose, wells of 96-well plates were coated overnight
at 4°C with rDsg-3 used at the concentration of 100
μg/ml in PBS. Bound antibodies were detected with
rabbit anti-human IgG conjugated with horseradish
peroxidise. To detect non-specific binding, the wells
were coated with BSA and the background binding
to such wells was subtracted from all samples before
data analysis
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Figure 3. Reorganization of cytoskeleton induced by anti-Dsg-3 autoantibodies. HaCaT cells were incubated for 24 h
with anti Dsg-3 autoantibodies isolated from patients in active (panel A, picture a) or remission stage (panel A, pic-
ture b) used at the concentration of 1 mg/ml. Control cells were incubated with IgG of healthy relatives (picture c)
or control donors (picture d) used at the same concentration. Then, HaCaT cells were rinsed with cold PBS, dipped
in –20°C methanol for 20 min and stained with Texas Red-X phalloidin to visualize actin filaments. Panel B shows
Western blot analysis of Bax, Bcl proteins and procaspase 3 levels in HaCaT cells incubated in the presence of anti
Dsg-3 autoantibodies isolated from PV patients at the active stage (lane a), patients in remission (lane b), healthy
relatives (lane c) and healthy donors (lane d). β-Actin was used as a control for SDS/PAGE loading
Figure 2. Binding of anti-Dsg-3 autoantibodies to HaCaT analysed by confocal microscopy. Cells grown directly on
tissue culture chamber slides were incubated with anti-Dsg-3 autoantibodies isolated from PV patients in the active
stage (A) or in remission (B) used at 1 mg/ml. Control cells were incubated with IgGs obtained from healthy rela-
tives (C) of control donors (D) also used at 1 mg/ml. Then they were rinsed with PBS, fixed with 3% paraformalde-
hyde for 20 min on ice, blocked with 10% normal goat serum and after blocking with BSA stained with goat anti-
human IgG conjugated with TRITC. Cell nuclei were visualized using Hoechst 33342
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a tendency to form cell-to-cell contacts (Figure 3 A,
picture b). It is noteworthy that structural changes
induced in keratinocytes by anti-Dsg-3 autoanti-
bodies shown in Figures 3 A were observed in
a number of cells (from 47 to 95) analysed by con-
focal microscopy during three separate experiments. 
Consistently, Western blot analysis showed
increased expression of Bax protein in human
HaCaT cells incubated with both types of anti-Dsg-3
autoantibodies. At the same time, the expression
of Bcl-2 and procaspase-3 was significantly
decreased in both groups, indicating that these
antibodies had pro-apoptotic activity when incu-
bated with keratinocytes (Figure 3 B). No differences
in Bax, Bcl-2 and procaspase-3 expression were
found between healthy relatives and healthy
donors.
Anti-Dsg-3 autoantibodies from pemphigus
vulgaris patients induce expression of 
proinflammatory cytokines in keratinocytes
Figure 4 shows that incubation of HaCaT cells
with anti Dsg-3 autoantibodies resulted in a signif-
icant increase of proinflammatory cytokines such
as IL-1β, IL-6, and TNF-α when analysed at their
mRNA level. Both types of autoantibodies showed
a similar activating effect, though those obtained
from patients in the active stage of the disease
appeared to be more effective; however, these dif-
ferences did not reach statistical significance. Sta-
tistical analysis of these data revealed that the only
significant differences in mRNA expression for 
IL-1β, IL-6, and TNF-α were between active PV stage
patients and healthy relatives (controls) (p < 0.05;
p < 0.01; p < 0.05, respectively) (Table I, Figure 4).
The mRNA uPAR expression in HaCaT cells under
incubation with anti-Dsg3 isolated from active PV
patients was higher than in the controls, but this
did not reach statistical significance. In contrast,
the expression of mRNA for this protein in HaCaT
cells stimulated by anti-Dsg-3 isolated from serum
of patients in the remission stage of PV was sig-
nificantly higher than in the cell lines stimulated by
IgGs from healthy relatives of PV patients (p < 0.01;
Table I, Figure 4).
Discussion
The positive correlation between titres of pem-
phigus autoantibodies and pemphigus activity has
been widely proven and the lack of antibodies in IIF
was established as a criterion to stop treatment.
However, in clinical practice we can observe by IIF
Expression  PV active PV remission
of mRNA Median Median
(interquartile  (interquartile 
range, range, 
25th-75th 25th-75th
percentile)p ercentile)
IL-1 [%] 141 (133-148.5) 129 (123.5-134.5)
IL-6 [%] 197 (188-205.5) 174.5 (169-183)
TNF-α [%] 142 (130-153.5) 127 (121-141)
uPAR [%] 117 (111.5-125) 178.5 (164.5-189.5)
Results are shown as the percentage (%) amount of detected mRNA
in each group of HaCat cell lines in comparison with mRNA expression
in the cell line stimulated with IgGs purified from healthy relatives of
pemphigus patients (100%)
Table I. mRNA expression of interleukin-1 (IL-1), inter-
leukin-6 (IL-6), tumour necrosis factor-α (TNF-α) and
receptor for urokinase-type plasminogen activator
(uPAR) in HaCaT cell lines stimulated with anti-Dsg3
antibodies isolated from patients in the active 
(PV active) and remission (PV remission) stage of PV
a b c
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β-actin
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Figure 4. Effect of anti-Dsg-3 autoantibodies on expression of cytokines and uPAR in keratinocytes. Total RNA was
extracted from the keratinocytes stimulated with anti-Dsg-3 autoantibodies isolated from PV patients at the active
stage (lane a), in remission (lane b) and healthy relatives (lane c), analysed by RT PCR using relevant primers. In pan-
el A mRNAs of IL-1β, IL-6, TNF-α, uPAR, and β-actin in HaCaT separated by electrophoresis in polyacrylamide gels
are shown. Bands were visualized by UV light, recorded photographically and analysed densitometrically using Mul-
tiImageTMFC Cabinet and FlourChemTMIS-8800 Software v.3.0. Panel B shows expression of mRNAs of cytokines and
uPAR normalized to the β-actin mRNA intensity
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circulating antibodies in low titres in patients in
whom there are no clinical lesions for a long time.
Such a situation causes a therapeutic problem and
prevents dermatologists from stopping treatment.
Based on these observations we aimed to assess
immunobiological properties of antibodies detect-
ed in patients in clinical remission in regard to their
ability to induce loss of cell-cell contact, enhance
mRNA expression of proteins involved in pemphi-
gus pathogenesis and to trigger apoptosis. 
The studies on the pathomechanism of acan-
tholysis are still being performed but the whole
process is not fully known. In multiple experimen-
tal studies it has been proven that PV-IgG causes
many biochemical phenomena including transient,
rapid increase in Ca2+, marked activation of phos-
pholipase C and transient increase in inositol 1,4,5-
triphosphate (IP3) in cultured human keratinocytes
[19]. The studies on the protein kinase C revealed
an increase in its activity after PV-IgG exposure and
determined its important role in mediating the
intracellular signalling events leading to loss of cell-
cell adhesion induced by PV-IgG binding to Dsg-3
[20, 21]. Many experiments have aimed to explain
the role of plasminogen activator in acantholysis.
The obtained results are controversial and still need
revision [22-26]. An increase in mRNAs for uroki-
nase plasminogen activator (uPA) and for plasmin
in cultured keratinocytes treated with PV-IgG was
found [27], and an increase in tissue plasminogen
activator mRNA in the perilesional skin from pem-
phigus patients was noted [28]. Based on these
results, one may speculate about a role of activa-
tion of uPA in proteolysis of cell-cell attachment in
pemphigus. Schuh et al. [29] tested inhibitors of
the plasminogen activator system (anti-uPA, anti-
tPA, anti-plasmin) with regard to their potential pro-
tective role. The authors found that these inhibitors
failed to prevent PV-IgG mediated acantholysis, but
acantholysis was effectively inhibited by the syn-
thetic active site serine protease inhibitor. On the
other hand, Xue et al. [30] suggest that monoclon-
al anti-uPAR antibodies have a protective role
against acantholysis development. By immunohis-
tochemical studies on the expression of plakoglo-
bin and uPAR, strong expression of uPAR was found
around acantholytic cells, probably resulting from
dissociation of plakoglobin and Dsg3 mediated by
PV-IgG binding [31]. Feliciani et al. [32] showed that
pemphigus antibodies enhanced mRNA expression
for uPA, IL-1β and TNF-α in vitro. They also con-
cluded that IL-1β and TNF-α increased expression
causes in the next step induction of urokinase plas-
minogen activator. Levels of several cytokines 
(IL-1β, IL-6, TNF-α) and inflammatory mediators
including prostaglandins (PGE2, PGF1, PGF2), throm-
boxane B2 and leukotrienes (LTB4, LTC4) were 
found to be increased in blister fluid and perile-
sional skin in pemphigus patients [33, 34]. It was
also shown that TNF-α induces uPA in human
endothelial cells treated with PV-IgG. Studies on the
role of proinflammatory cytokines in pemphigus
revealed that by using anti-IL-1 and anti-TNF-α anti-
bodies one may inhibit IgG-mediated acantholysis
in vitro [35]. These studies and other reports indi-
cate that IL-1 and TNF-α are overexpressed in PV
and highlight their potential involvement in the
pathogenesis of pemphigus. All the studies con-
cerning expression of uPA and cytokines were per-
formed with the use of PV-IgG obtained from
patients at the active stage of the disease, while
the role of antibodies found in patients in clinical
remission or from healthy relatives has not been
studied. Thus we attempted to analyse the influ-
ence of the latter on these phenomena. In our
experiment we showed that anti-Dsg-3 antibodies
isolated both from active and remission patients
have the ability to bind at the surface of HaCaT cells
and induce loss of cell-to-cell adhesion. After cell
culture stimulation with these antibodies, increased
expression of mRNAs for examined proinflamma-
tory cytokines (IL-1β, TNF-α and IL-6) was observed,
which proves their role in pathogenesis of PV and
is in line with observations of other authors [36,
37]. Although anti-Dsg-3 antibodies purified from
remission patients’ sera did not cause statistically
enhanced mRNA expression, they influenced this
process, while IgGs from healthy relatives did not
affect it at all. This observation proves the distinct
properties of antibodies giving a “pemphigus-like”
pattern in IIF isolated from healthy relatives and
explains their lack of ability to initiate acantholy-
sis. In contrast, uPAR mRNA expression was statis-
tically increased under HaCaT incubation with anti-
Dsg-3 antibodies purified from sera of patients in
clinical remission, which may suggest the role of
uPAR in maintaining the pathological process in lat-
er phases of the disease. Also in this case IgGs from
healthy relatives caused no changes. 
Abnormal activation of apoptosis and distur-
bances in apoptotic cell clearance may result in
decreasing immunological tolerance and, as a con-
sequence, the production of autoantibodies and the
development of autoimmune diseases [38]. Cur-
rently, based on performed studies, apoptosis is
accepted as one of the factors involved in acan-
tholysis development [39, 40].
Caspases are key mediators in induction of apop-
tosis in different cells, among which caspase-3 is
known to play one of major roles in the process [41].
Keratinocyte apoptosis level may be established as
the ratio of pro-apoptotic (Bax) and anti-apoptotic
(Bcl-2) proteins from the Bcl-2 family. It was demon-
strated that Bcl-2 can protect HaCaT cells against
apoptosis [42] while apoptotic inducers enhance
Bax protein expression [43]. Arch Med Sci 2, April / 2012 355
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In our study the decreased level of procaspase-3
(inactive form of caspase-3), which may be consid-
ered as a marker of increased apoptosis, with simul-
taneously a high level of Bax and a low level of 
Bcl-2, suggests that purified anti-Dsg-3 antibodies
obtained from active and remission PV patients are
sufficient to cause a pro-apoptotic effect. Similar
observations were obtained by Pelacho et al. [44],
who showed in HaCaT cells that IgGs purified from
patients with the mucocutaneous form of PV
caused an apoptotic effect. These results suggest
that anti-Dsg-3 antibodies may contribute to PV
pathogenesis by enhancement of apoptosis. The
IgGs isolated from healthy relatives of PV patients
and from controls showed no pro-apoptotic effect,
which testifies to their different immunobiological
properties when compared to pemphigus autoan-
tibodies circulating in the patients. 
There are some controversial data revealing the
presence of pemphigus antibodies in healthy rela-
tives. However, in the majority of experiments these
antibodies had no ability to bind in vivo with ker-
atinocytes’ superficial antigens and this observa-
tion raised the question of their significance. It was
also raised whether the subjects with these anti-
bodies are at increased risk for pemphigus devel-
opment and whether they should be followed up.
Our results seem to partially answer these ques-
tions and suggest that antibodies detected by IIF
in healthy relatives are in fact “false” pemphigus
antibodies, and the observed “fishnet-like” pattern
might result from their binding to keratinocyte
superficial antigens other than desmogleins, but
this observation still requires further investigations. 
The results obtained also give objective reasons
for the necessity of long-term maintenance treat-
ment of PV patients when any circulating antibod-
ies are detected despite the lack of clinical mani-
festation. 
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